Lessons from GRACE: The Global Registry of Acute Coronary Events

European Heart Journal, Supplement

Volumn 4, Issue 5, 2002, Pages

  Eagle, K ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Coronary disease; Heart disease; Myocardial ischaemia; Registries

Indexed keywords

ANTITHROMBIN; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; RETEPLASE; STREPTOKINASE; TENECTEPLASE; TIROFIBAN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; CANCER REGISTRY; CLINICAL TRIAL; CONFERENCE PAPER; CORONARY ARTERY BYPASS SURGERY; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; ISCHEMIC HEART DISEASE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; SIDE EFFECT; ST SEGMENT ELEVATION; THROMBOCYTOPENIA; UNSTABLE ANGINA PECTORIS; WORLD HEALTH ORGANIZATION;

EID: 0141478279     PISSN: 1520765X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1520-765X(02)90083-0     Document Type: Conference Paper

References (31)

1. Langmuir AD. William Farr: founder of modern concepts of surveillance. Int J Epidemiol 1976; 5: 13-8.
2. Susser M, Adelstein A. An introduction to the work of William Farr. Am J. Epidemiol 1975; 101: 469-76.
3. Thacker SB. Historical development. In: Churchill RE, ed. Principles and Practice of Public Health Surveillance, 2nd Edition. New York, Oxford University Press, 2000: 1-16.
4. Wagner G. Cancer registration: historical aspects. IARC Sci Publ 1985: 3-12.
5. Teutsch SM. Considerations in planning a surveillance system. In: Churchill RE, ed. Principles and Practice of Public Health Surveillance, 2nd Edition. New York, Oxford University Press, 2000: 17-26.
6. Berkelman RL, Stroup DF, Buehler JW. Public health surveillance. In: Omenn GS, ed. Oxford Textbook of Public Health, 3rd Edition. New York, Oxford University Press, 1997: 735-50.
7. Birkhead GS, Maylahn CM. State and local public health surveillance. In: Churchill RE, ed. Principles and Practice of Public Health Surveillance, 2nd Edition. New York, Oxford University Press, 2000: 253-86.
8. Dyke CK, Calif RM. National and regional registries: what good are they? Eur Heart J 2000; 21: 1401-3.
9. Hearst N, Grady D, Barron HV et al. Research using existing data: secondary data analysis, ancillary studies, and systematic reviews. In: Newman TB, ed. Designing Clinical Research: An Epidemiologic Approach, 2nd Edition. Philadelphia, Lippincott Williams & Wilkins, 2001: 195-212.
10. Dawson BD, Trapp R. In: Basic and Clinical Biostatistics, 3rd Edition. New York, Lange Medical Books/McGraw Hill, 2001: 7-23.
11. Cummings SR, Newman TB, Hulley SB. Designing an observational study: cohort studies. In: Newman TB, ed. Designing Clinical Research: An Epidemiologic Approach, 2nd Edition. Philadelphia, Lippincott Williams & Wilkins, 2001: 95-105.
12. Newman TB, Browner WS, Cummings SR et al. Designing an observational study: cross-sectional and case-control studies. In: Newman TB, ed. Designing Clinical Research: An Epidemiologic Approach, 2nd Edition. Philadelphia, Lippincott Williams & Wilkins, 2001: 107-23.
13. Cummings SR, Grady D, Hulley SB. Designing an experiment: clinical trials I. In: Newman TB, ed. Designing Clinical Research: An Epidemiologic Approach, 2nd Edition. Philadelphia, Lippincott Williams & Wilkins, 2001: 143-55.
14. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring Trends and Determinants in Cardiovascular Disease. Lancet 1999; 353: 1547-57.
15. Tunstall-Pedoe H. Monitoring trends in cardiovascular disease and risk factors: the WHO 'Monica' project. WHO Chron 1985; 39: 3-5.
16. Tunstall-Pedoe H, Vanuzzo D, Hobbs M et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000; 355: 688-700.
17. Brindis RG, Fitzgerald S, Anderson HV, Shaw RE, Weintraub WS, Williams JF. The American College of Cardiology-National Cardiovascular Data Registry (ACC-NCDR): building a national clinical data repository. J Am Coll Cardiol 2001; 37: 2240-5.
18. Rogers WJ, Canto JG, Lambrew CT et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. J Am Coll Cardiol 2000; 36: 2056-63.
19. Finlay A, Cosovich C, Gebur S. A national disease registry moves beyond clinical impact, fostering measurable cost savings at the community hospital level. J Health Care Finance 2000; 27: 8-29.
20. Anand SS. The Organization to Assess Strategies for Ischemic Syndromes (OASIS) pilot study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation. Am J Cardiol 1999; 84: 13M-9M.
21. Collinson J, Flather MD, Fox KA et al. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK). Eur Heart J 2000; 21: 1450-7.
22. Fox KA, Cokkinos DV, Deckers J, Keil U, Maggioni A, Steg G. The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment. Eur Heart J 2000; 21: 1440-9.
23. Fox KAA. An introduction to the Global Registry of Acute Coronary Events: GRACE. Eur Heart J Suppl 2000; 2: F21-4.
24. Granger CB. Strategies of patient care in acute coronary syndromes: rationale for the Global Registry of Acute Coronary Events (GRACE) registry. Am J Cardiol 2000; 86: 4M-9M.
25. Anonymous. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) project: a multinational registry of patients hospitalized with acute coronary syndromes. Am Heart J 2001; 141: 190-9.
26. Ryan TJ, Antman EM, Brooks NH et al. 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 1999; 34: 890-911.
27. Braunwald E, Antman EM, Beasley JW et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000; 36: 970-1062.
28. Cohen M, Demers C, Gurfinkel EP et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group. N Engl J Med 1997; 337: 447-52.
29. Antman EM, McCabe CH, Gurfinkel EP et al. Enoxaparin prevents death and cardiac ischemic events in unstable angina/ non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial. Circulation 1999; 100: 1593-601.
30. Sadiq I, Eagle KA, Agnelli G et al. Role of glycoprotein IIb/IIIa antagonists in patients with acute coronary syndromes: comparison of clinical trial data with the global registry of acute coronary events (GRACE) [abstract]. Eur Heart J 2001; 22: 519.
31. Cannon CP, Van de Werf F, Avezum A et al. Safety of the combination of low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors: observations from the global registry of acute coronary events (GRACE) [abstract]. Eur Heart J 2001; 22: 592.